To assess the impact of VISTA expression on the establishment of an immunosuppressive microenvironment in breast cancer, a comparison was made with the main inhibitory immune checkpoints used in immunotherapy, namely PD-1, PDL-1 and CTLA-4. The gene discussed is CD274; the disease is breast carcinoma.